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Abstract
The transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1a) is a chief
activator of mitochondrial and metabolic programs and protects against atrophy in skeletal muscle (skm). Here we tested
whether PGC-1a overexpression could restructure the transcriptome and metabolism of primary cultured human skm cells,
which display a phenotype that resembles the atrophic phenotype. An oligonucleotide microarray analysis was used to
reveal the effects of PGC-1a on the whole transcriptome. Fifty-three different genes showed altered expression in response
to PGC-1a: 42 upregulated and 11 downregulated. The main gene ontologies (GO) associated with the upregulated genes
were mitochondrial components and processes and this was linked with an increase in COX activity, an indicator of
mitochondrial content. Furthermore, PGC-1a enhanced mitochondrial oxidation of palmitate and lactate to CO2, but not
glucose oxidation. The other most significantly associated GOs for the upregulated genes were chemotaxis and cytokine
activity, and several cytokines, including IL-8/CXCL8, CXCL6, CCL5 and CCL8, were within the most highly induced genes.
Indeed, PGC-1a highly increased IL-8 cell protein content. The most upregulated gene was PVALB, which is related to
calcium signaling. Potential metabolic regulators of fatty acid and glucose storage were among mainly regulated genes. The
mRNA and protein level of FITM1/FIT1, which enhances the formation of lipid droplets, was raised by PGC-1a, while in
oleate-incubated cells PGC-1a increased the number of smaller lipid droplets and modestly triglyceride levels, compared to
controls. CALM1, the calcium-modulated d subunit of phosphorylase kinase, was downregulated by PGC-1a, while glycogen
phosphorylase was inactivated and glycogen storage was increased by PGC-1a. In conclusion, of the metabolic
transcriptome deficiencies of cultured skm cells, PGC-1a rescued the expression of genes encoding mitochondrial proteins
and FITM1. Several myokine genes, including IL-8 and CCL5, which are known to be constitutively expressed in human skm
cells, were induced by PGC-1a.
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Introduction
The transcriptional coactivator PGC-1a, which regulates target
genes through its interaction with diverse transcription factors and
the recruitment of chromatin-remodelling complexes [1,2], has
been reported to play a major role in skm in both mitochondrial
biogenesis and function [2] and metabolic programming [3,4]; and
in particular in metabolic adaptations to exercise [3,4].
Induction of genes encoding mitochondrial proteins and
mitochondrial biogenesis is one of the most powerful and
consistent actions of PGC-1a in skm. Supporting data derive
mostly from mouse studies. PGC-1a gene expression is enriched in
skm type I (slow-twitch) fibers, which have a higher mitochondrial
content and are more dependent on oxidative metabolism than
type II (fast-twitch) fibers, which mainly use the glycolytic pathway
[5]. Skm-specific transgenic overexpression of PGC-1a induces
genes involved in mitochondrial electron transport [5,6] and
increases mitochondrial content [6]. Conversely, skm-specific
PGC-1a knockout mice show decreased mitochondrial gene
expression and function [7] or an attenuated exercise-induced
rise in some mitochondrial electron transport chain proteins [8].
Furthermore, the expression of oxidative phosphorylation genes is
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proposed that the powerful stimulation of mitochondrial function
by PGC-1a is coordinately regulated with fiber type composition
[5,10], but not all data support this hypothesis [8,9]. In transgenic
mice, in which PGC-1a is controled by a promoter that is
preferentially activated in type II fibers, induction of mitochon-
drial protein genes is linked to that of contractile protein genes
enriched in type I fibers [5]. On the other hand, skm-specific
PGC-1a knockout mice have a higher percentage of the glycolytic
type IIx and IIb fibers at the apparent expense of the loss of
oxidative type I and IIa fibers in different skm beds [10]. However,
in another study using this type of murine model, endurance
exercise-induction of IIb-to-IIa fiber type transformation was not
attenuated by PGC-1a knockout [8]. Moreover, in PGC-1a
knockout mice [9], no differences in fiber type composition were
observed in the type I fiber-rich soleus muscle. Data on human
skm are more limited. In one study, the amount of PGC-1a
protein in different fiber types was found to follow the order: type
IIa (fast oxidative-glycolytic).type I (slow oxidative).type IIx (fast
glycolytic) fibers [11]. In another study [12], the percentage of type
I fibers in human skm was positively correlated, and that of type
IIa and type IIb (very fast glycolytic) fibers was negatively
correlated, with PGC-1a mRNA.
PGC-1a orchestrates glucose and fatty acid metabolism in skm
by regulating fatty acid and glucose utilization as fuel for oxidative
phosphorylation. In this sense, PGC-1a enhanced the complete
oxidation of fatty acids [13–15], while it inhibited glucose
oxidation [13,16] in cultured myotubes. Palmitate oxidation was
also enhanced in subsarcolemmal mitochondria by PGC-1a
overexpression in rat skm [17]. However, both strong stimulation
of glucose uptake and slightly increased oxidation by PGC-1a was
observed in C2C12 myotubes [18]. In addition, PGC-1a increases
fuel stores despite the enhanced mitochondrial oxidative metab-
olism. In this regard, skm-specific PGC-1a overexpression in
transgenic mice increased glucose uptake, glycogen and lipid
droplet content [6]. In another transgenic murine model of skm-
specific PGC-1a overexpression, higher intramyofibrillar lipid
levels, including triglycerides, were detected [19]. In cultured
human myotubes from lean and obese subjects, PGC-1a increased
oleate incorporation into triglycerides [15].
PGC-1a is also involved in the maintenance of skm function
and protection against damage. PGC-1a gene expression in skm is
reduced in different conditions associated with atrophy, such as
denervation in mice [20], spinal cord injury [12] and aging [21] in
humans. Additionally, skm-specific knockout of the PGC-1a gene
causes fiber damage and exercise intolerance in mice [10]. On the
other hand, transgenic skm-specific PGC-1a overexpression
reduces muscle wasting and the induction of atrophy-related
genes due to denervation and fasting in mice [22]. Moreover,
transgenic expression of PGC-1a in skm ameliorates a murine
model of Duchenne muscular dystrophy (mdx) [23] and preserves
mitochondrial function, neuromuscular junctions and muscle
integrity during aging [24].
In this context, we aimed to establish whether PGC-1a
overexpression could ameliorate the transcriptome and metabo-
lism of primary cultured human skm cells, which display a
reductive metabolic and muscle system transcriptome, compared
to skm tissue, which resembles the atrophic phenotype [25]. Thus,
we examined the effects of PGC-1a on the whole skm cell
transcriptome and its possible relation to regulation of fatty acid
and glucose metabolism. We show that PGC-1a activates the
muscle cell transcriptional program of mitochondrial protein genes
and mitochondrial biogenesis, whereas adult contractile protein
genes are not regulated. We identify key metabolic control genes in
fatty acid and glucose storage as new PGC-1a-target genes.
Finally, a striking finding of this study is that PGC-1a activates a
transcriptional program of myokines.
Results
Effects of PGC-1a on the cultured skm cell transcriptome
We first assessed whether PGC-1a transcript levels were altered
in cultured skm cells compared to the biopsied paravertebral skm,
composed of type I and type II fibers in similar proportions
[26,27], from which they were derived. We found that cultured
skm cells had 16.4-fold lower PGC-1a mRNA levels than the skm
biopsies (Figure 1A). We then overexpressed PGC-1a in the
cultured skm cells using an adenovirus (Ad-PGC-1a) that encodes
both mouse PGC-1a and EGFP proteins under the control of two
separate CMV promoters, while control skm cells were treated
with an adenovirus encoding EGFP (Ad-GFP). A probe for the
mouse PGC-1a transcript revealed a gene expression level of
0.2660.07 relative to the B2M gene in PGC-1a-cells, but no
signal in control cells. A probe for human PGC-1a mRNA
detected mouse PGC-1a mRNA in PGC-1a-cells (Figure 1B), at
similar levels to the mouse-specific probe, thus showing that PGC-
1a mRNA levels in PGC-1a-cells were close to those in the skm
tissue. Immunoblotting analyses were carried out to quantify
PGC-1a and GFP protein levels, the latter to control for
adenoviral transduction load. PGC-1a protein content was
increased by 7-fold in PGC-1a-cells compared to controls
(Figure 1C). GFP analysis showed equivalent expression levels of
the marker gene in controls and PGC-1a-cells (data not shown),
indicating equivalent adenoviral transduction load.
An oligonucleotide microarray analysis was performed to reveal
the effect of PGC-1a at the whole skm cell transcriptome level.
Fifty-three different genes showed altered expression in cultured
muscle cells overexpressing PGC-1a compared to control cells
using the selection criteria of absolute fold change value .1.50
and p,0.025 (no significant differences were observed when using
the corrected p-value). Of these, a majority (42 genes) were
upregulated and only 11 were downregulated (Table 1).
When GO tools were applied to the 53 differentially expressed
genes in microarray (separately for upregulated and downregulat-
ed genes), and ontology selection criteria were restricted to an
adjusted p value,0.01, only upregulated genes showed a
significant association with GO (Table 2). With respect to the
Cellular component, the main regulated GOs were related to
mitochondria. Among the most regulated Biological processes
were those involved in the generation of precursor metabolites and
energy (including oxidation, cellular respiration and electron
transport chain), those involving cytokines (such as wounding,
locomotory behavior, inflammatory response, chemotaxis, taxis
and leukocyte chemotaxis) and those participating in the removal
or response to superoxide radicals. Remarkably, the most
regulated Molecular function was the chemokine/cytokine-related
function. Similar results were obtained when using KEGG (Kyoto
Encyclopedia of Genes and Genomes) tools, i.e. the most regulated
pathways were metabolic, chemokine and NOD-like receptor
signaling pathways, cytokine-cytokine receptor interaction and
Huntington’s disease (data not shown).
To reveal the genes that were regulated in common in cultured
skm cells by PGC-1a and in cultured skm cells compared to the
skm biopsies, microarray data in this and our previous study [25]
were analyzed together. As shown in Figure 2, nine genes were
identified overall. All 7 genes that were downregulated by skm
culture were induced by PGC-1a. Two of these genes (CYCS and
SDHB) are involved in the electron transport system. Others
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(SFXN4), cation pumping (ATP1B) and the control of lipid
metabolism (FITM1) [28]; and one was the estrogen-related
receptor ESRRA. Of the two genes that were upregulated by skm
culture, the transcription factor SNAI2, which triggers epithelial-
mesenchymal transitions, was downregulated by PGC-1a, and the
carbonic anhydrase CA12 was further upregulated PGC-1a.
The altered expression for 11 genes chosen from those identified
in the oligonucleotide microarray was analyzed by reverse
transcription (RT) and real-time PCR (Table 3). Altered
expression was confirmed in all cases. The most upregulated gene
in the microarray, PVALB, was one of these selected genes and the
fold change measured by RT and real-time PCR was about 12,
which was much higher than that measured in the microarray.
Other genes were selected to represent the most regulated GOs,
i.e. mitochondria (SLC25A4), chemokine activity (IL-8, CXCL6,
CCL5 and CCL8) and an inhibitor of the NF-kappaB (NF-kB)
complex (NFKBIA); and metabolic control (FITM1, SLC2A5,
ARRPP-21 and CALM1). Among the selected upregulated genes,
similar increases to those detected by the microarray were
observed, except for FITM1, whose increment was higher in the
RT and real-time PCR than in the microarray analysis. The two
selected downregulated genes, ARPP-21 and CALM1, showed an
absolute fold change value that was also higher according to RT
and real-time PCR.
The changed expression of two genes IL-8 and FITM1, was
assessed at the protein level. IL-8 protein content in cell extracts
from PGC-1a-cells was about 36-fold higher than in control cells
(Figure 3A). IL-8 protein could not be detected in 48 h-
conditioned media of neither PGC-1a- or control-cells, indicating
that it is accumulated rather than secreted in cultured muscle cells.
FITM1 protein content was 2.7-fold higher in PGC-1a-cells
compared to controls (Figure 3B).
Metabolic effects of PGC-1a overexpression in cultured
muscle cells
To evaluate whether PGC-1a was regulating mitochondrial
biogenesis in our cell model, we measured cytochrome c oxidase
(COX) activity cytochemically and mitochondrial DNA content
relative to nuclear DNA content. COX activity is a marker of
mitochondrial content because it involves genes from the
mitochondrial as well as nuclear genome. The intensity of COX
activity staining was about 4-fold higher in cells overexpressing
PGC-1a than in the controls (Figure 4A). In response to PGC-1a,
a trend for higher mitochondrial to nuclear DNA ratio was
observed, although this did not reach statistical significance
(Figure 4B).
We then analyzed the mitochondrial oxidation of metabolic
substrates to CO2. First, fatty acid oxidation was assessed by
14CO2 release from [1-
14C]-palmitate (Figure 4C), revealing that it
was enhanced by 13% in response to PGC-1a overexpression. In
contrast, [U-
14C]-glucose oxidation was unaltered by the forced
expression of PGC-1a (Figure 4D), whereas [U-
14C]-lactate
oxidation was increased by 18% (Figure 4E). A PGC-1a inhibitory
effect on glucose oxidation has been repeatedly reported for skm in
association with the induction of pyruvate dehydrogenase kinase-4
(PDK4) gene expression [13,16]. Thus, we measured PDK4
mRNA levels by RT and real-time PCR and found that they were
increased in PGC-1a-overexpressing cells compared to controls
(1.8-fold, p,0.001).
We examined whether the lipid droplet content was modified in
cultured skm cells treated with Ad-PGC-1a or Ad-GFP and
incubated with oleate, a fatty acid that drives triglyceride synthesis
(Figure 5A). In these conditions, PGC-1a overexpressing cells
showed a 2.5-fold higher number of lipid droplets per cell
(Figure 5B), but these droplets were smaller (70% lower mean area
values) than controls (Figure 5C). The triglyceride content in cells
incubated with oleate was increased by about 40% (Figure 5D).
Since greater lipid accumulation by PGC-1a in skm has been
associated with powerful upregulation of the FAT/CD36 gene in
transgenic mice [5,6,19,29], we measured its mRNA levels. We
found that FAT/CD36 transcript levels, as assessed by RT and
Figure 1. PGC-1a gene expression. (A,B) Human PGC-1a mRNA
levels were determined relative to B2M using RT and real-time PCR. (A)
Six samples were analyzed, three from cultured skm cells and three
from skm biopsies. Data are expressed as mean values 6 SEM of 2
2DCt.
The significance of the difference is *p,0.05. (B) Cultured skm cells
were transduced with Ad-GFP or Ad-PGC-1a. Data are expressed as
mean values 6 SEM of 2
2DCt for three experiments performed in
triplicate. The significance of the difference is *p,0.001. (C) Cultured
skm cells were transduced with Ad-GFP or Ad-PGC-1a. Immunoblot
analyses were performed on nuclear cell extracts (30 mg protein) and
membranes were hybridized with antibodies against PGC-1a and a-
actin. A representative image is shown. Bands were quantified with
ImageQuant LAS 4000. Data are means 6 SEM from two experiments
performed in triplicate. Significance of differences versus cells treated
with Ad-GFP: *p,0.05.
doi:10.1371/journal.pone.0029985.g001
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RefSeq Gene symbol Gene description FC P value
Upregulated
NM_002854.2 PVALB parvalbumin +3.17 0.0049
NM_001825.1 CKMT2 creatine kinase, mitochondrial 2 (sarcomeric) +3.04 0.0220
NM_000584.2 IL8 interleukin 8 +3.02 0.0108
NM_002993.2 CXCL6 chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) +2.98 0.0068
NM_002985.2 CCL5 chemokine (C-C motif) ligand 5 +2.95 0.0017
NM_005952.2 MT1X metallothionein 1X +2.55 0.0034
NM_001024466.1 SOD2 superoxide dismutase 2, mitochondrial +2.39 0.0003
NM_005623.2 CCL8 chemokine (C-C motif) ligand 8 +2.25 0.0001
NM_001151.2 SLC25A4 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 +2.25 8.89E-06
NM_001677.3 ATP1B1 ATPase, Na+/K+ transporting, beta 1 polypeptide +1.93 0.0003
NM_002038.2 G1P3 Homo sapiens interferon, alpha-inducible protein (clone IFI-6-16) (G1P3) +1.93 0.0194
NM_020529.1 NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha +1.92 0.0002
NM_005954.2 MT3 metallothionein 3 +1.89 0.0014
NM_005530.2 IDH3A isocitrate dehydrogenase 3 (NAD+) alpha +1.86 0.0241
NM_001785.1 CDA cytidine deaminase +1.86 0.0159
NM_213720.1 CHCHD10 coiled-coil-helix-coiled-coil-helix domain containing 10 +1.80 0.0147
NM_032321.1 C2orf88 chromosome 2 open reading frame 88 +1.75 0.0101
NM_181679.1 NFS1 NFS1 nitrogen fixation 1 homolog (S. cerevisiae) +1.73 0.0032
NM_022153.1 C10orf54 chromosome 10 open reading frame 54 +1.73 0.0002
NM_022440.1 MAL mal, T-cell differentiation protein +1.73 0.0036
NM_181755.1 HSD11B1 hydroxysteroid (11-beta) dehydrogenase 1 +1.72 0.0098
NR_001561.1 CYCS cytochrome c, somatic +1.71 0.0003
NM_006114.1 TOMM40 translocase of outer mitochondrial membrane 40 homolog (yeast) +1.69 0.0002
NM_213650.1 SFXN4 sideroflexin 4 +1.69 0.0002
NM_001629.2 ALOX5AP arachidonate 5-lipoxygenase-activating protein +1.67 0.0027
NM_005950.1 MT1G metallothionein 1G +1.65 0.0184
NM_002982.3 CCL2 chemokine (C-C motif) ligand 2 +1.64 0.0110
NM_016098.1 BRP44L brain protein 44-like +1.64 0.0020
NM_003155.2 STC1 stanniocalcin 1 +1.63 0.0042
NM_032231.4 FAM96A family with sequence similarity 96, member A +1.63 0.0019
NM_003039.1 SLC2A5 solute carrier family 2 (facilitated glucose/fructose transporter), member 5 +1.62 0.0067
NM_198434.1 AURKA aurora kinase A +1.60 0.0010
NM_006528.2 TFPI2 tissue factor pathway inhibitor 2 +1.60 0.0066
NM_206963.1 RARRES1 retinoic acid receptor responder (tazarotene induced) 1 +1.60 0.0051
NM_004451.3 ESRRA estrogen-related receptor alpha +1.60 0.0001
NM_003000.1 SDHB succinate dehydrogenase complex, subunit B, iron sulfur (Ip) +1.59 0.0024
NM_001710.4 CFB complement factor B +1.57 0.0119
NM_203402.1 FITM1 fat storage-inducing transmembrane protein 1 +1.57 0.0016
NM_198594.1 C1QTNF1 C1q and tumor necrosis factor related protein 1 +1.57 0.0003
NM_014222.2 NDUFA8 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19 kDa +1.53 0.0003
NM_004753.4 DHRS3 dehydrogenase/reductase (SDR family) member 3 +1.53 0.0036
NM_001218.3 CA12 carbonic anhydrase XII +1.51 0.0120
Downregulated
NM_014059.1 C13orf15 chromosome 13 open reading frame 15 21.73 0.0024
NM_002472.1 MYH8 myosin, heavy chain 8, skeletal muscle, perinatal 21.64 0.0007
NM_016300.4 ARPP-21 cyclic AMP-regulated phosphoprotein, 21 kD 21.64 0.0094
NM_006009.2 TUBA1A tubulin, alpha 1a 21.62 0.0002
NM_201525.1 GPR56 G protein-coupled receptor 56 (GPR56) 21.61 0.0096
NM_032645.3 RAPSN receptor-associated protein of the synapse 21.59 0.0144
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compared to controls (data not shown).
Finally, we assessed glucose incorporation into glycogen. As
shown in Figure 6A, this was markedly increased (about 2-fold) in
response to PGC-1a. In contrast, glucose uptake was not
(Figure 6B). To obtain more insight into the mechanism of action
of PGC-1a in glycogen accumulation we measured the activity of
glycogen synthase (Figure 6C) and glycogen phosphorylase
(Figure 6D). The activity ratio of glycogen synthase (2/+glucose
6-phosphate) was unaffected by PGC-1a, as was total glycogen
synthase activity (11.0061.90 mU/mg protein in PGC-1a-cells
and 9.2261.62 mU/mg protein in control cells). The glycogen
phosphorylase activity ratio (2/+AMP) was reduced by PGC-1a
(37%), whereas total glycogen phosphorylase activity did not differ
between the two groups (547660 mU/mg protein in PGC-1a-
cells versus 508666 in controls). This reduced activation state of
glycogen phosphorylase, together with no change in glycogen
synthase activity, may explain the observed increase in the storage
of glucose as glycogen in response to PGC-1a.
Discussion
Cultured human skm cells, which display an atrophy-related
transcriptome including metabolic and muscle system downregu-
lation [25], are shown here to have decreased PGC-1a mRNA
levels compared to the biopsied skm. This is in line with the
observations of reduced PGC-1a gene expression in atrophy due
to different basis including denervation [12,20], which may
account, at least in part, for the atrophic-related phenotype of
the cultured skm cells.
The core effect of overexpressed PGC-1a on the cultured skm
cell transcriptome, as revealed by an oligonucleotide microarray
analysis, is the enrichment in the expression of genes related to
mitochondrial components and processes, such as cellular
respiration and the electron transport chain. This finding is
consistent with other microarray analyses exploring the effects of
PGC-1a at the whole skm cell transcriptome level [9,14]. In rat L6
myotubes, adenovirus-mediated PGC-1a overexpression activated
the expression of genes involved in the tricarboxylic acid, the
electron transport chain and oxidative phosphorylation [14]. The
expression of genes necessary for mitochondrial function was
reduced in the skm of PGC-1a knockout mice, and these same
genes were induced in C2C12 muscle cells with adenovirus-
mediated overexpression of PGC-1a [9]. Moreover, several studies
have reported the upregulation of diverse mitochondrial oxidative
phosphorylation genes by PGC-1a in skm murine cells, as
reviewed in [1,3,4]. According to our microarray data, the main
mitochondrial protein PGC-1a target genes in human skm cells
are the adenine nucleotide translocator SLC25A4/ANT1, the
electron transporter CYCS and the oxidative stress resistance gene
SOD2, all of which have been previously described as PGC-1a-
induced genes [8,9,14,24]. Our findings reinforce the notion that
stimulation of the transcriptional mitochondrial program by PGC-
1a does not require innervation, as previously observed in
denervated skm of transgenic mice overexpressing PGC-1a [22].
Moreover, inspection of the genes that are regulated both by skm
culture and PGC-1a-overexpression in cultured skm cells revealed
that two downregulated mitochondrial protein genes were rescued
by PGC-1a: CYCS and the beta subunit of the succinate
dehydrogenase complex, SDHB, a component of the mitochon-
drial complex II. This demonstrates that PGC-1a can rescue the
expression of some of the mitochondrial protein genes that are
deficient in the cultured skm cells compared to the tissue from
which they were derived and in this sense PGC-1a-cells
transcriptome is more similar to that of skeletal muscle tissue.
PGC-1a stimulated mitochondrial biogenesis in our cultured
skm cells, as indicated by the increase in cytochemical COX
activity and the trend for higher mitochondrial to nuclear DNA
ratio. The positive link between COX activity and PGC-1a gene
expression has been established in tissues of varying oxidative
capacity and in skm in response to contractile activity and thyroid
hormone treatment in rats [30]. Furthermore, skm-specific
transgenic expression of PGC-1a prevents the decline in COX
activity during aging in mice [24] and the reduction in COX
activity in a mouse model of mitochondrial myopathy caused by a
skm-specific deletion of COX10 [31]. On the contrary, the
reduction in COX activity is associated with the lack of PGC-1a in
the skm tissue of the PGC-1a knockout mouse model [32]. We
detected slight increases in the oxidation rate of palmitate and
lactate in response to PGC-1a, in agreement with the observed rise
in mitochondrial biogenesis, but no increase in glucose oxidation.
As shown previously [13,16], we found that this is associated with
an increase in the mRNA levels of PDK4, the kinase that
inactivates pyruvate dehydrogenase, which catalyses the oxidative
decarboxylation of pyruvate to acetyl-CoA that can then enter the
tricarboxylic acid cycle in the mitochondria.
PGC-1a-mediated induction of mitochondria related genes in
cultured human skm cells was not accompanied by a switch in the
fiber type-specific profile of contractile proteins. Only MYH8,
which is an embryonic isoform, was among the most highly
downregulated genes. This isoform is abundant in the cultured
skm cells, which co-express fast-twitch adult (MYH2 and MYL1)
and embryonic (MYH3, MYH8 and MYL4) skm myosin heavy
RefSeq Gene symbol Gene description FC P value
NM_001031692.1 LRRC17 leucine rich repeat containing 17 21.56 0.0002
NM_006888.2 CALM1 calmodulin 1 (phosphorylase kinase, delta) 21.53 0.0008
NM_000362.4 TIMP3 TIMP metallopeptidase inhibitor 3 21.52 0.0008
NM_003068.3 SNAI2 snail homolog 2 (Drosophila) 21.52 0.0036
NM_003246.2 THBS1 thrombospondin 1 21.51 0.0003
Microarray analysis was performed on six cultured skm cell samples from three independent experiments, three transduced with Ad-GFP and three with Ad-PGC-1a
adenovirus. The table lists the 53 regulated gene transcripts selected on the basis of the fold change (FC) and ordered by the magnitude of the absolute FC. Replicated
genes, which occurred more than once in the microarray, were filtered: those appearing first in the list were arbitrarily chosen. The first column lists the NCBI Reference
Sequence (RefSeq) accession number of the transcripts, the second the gene symbol, the third the description of the gene, the fourth the FC (with a positive symbol for
upregulated genes and a negative symbol for downregulated ones) and the fifth the significance of differences as estimated by a paired t-test.
doi:10.1371/journal.pone.0029985.t001
Table 1. Cont.
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GENE ONTOLOGIES OF UPREGULATED GENES
GO Term GO term description Number of genes Adj p-value
Cellular component
GO:0005739 mitochondrion 12 0.00097
GO:0044429 mitochondrial part 10 0.00050
GO:0031975 envelope 10 0.00066
GO:0031967 organelle envelope 10 0.00069
GO:0005740 mitochondrial envelope 9 0.00029
GO:0031966 mitochondrial membrane 8 0.00090
GO:0005743 mitochondrial inner membrane 6 0.00429
GO:0019866 organelle inner membrane 6 0.00454
Biological process
GO:0042221 response to chemical stimulus 13 0.00105
GO:0065008 regulation of biological quality 13 0.00259
GO:0009605 response to external stimulus 9 0.00756
GO:0009611 response to wounding 8 0.00266
GO:0048878 chemical homeostasis 7 0.00741
GO:0007626 locomotory behavior 6 0.00364
GO:0006091 generation of precursor metabolites and energy 6 0.00422
GO:0006954 inflammatory response 6 0.00427
GO:0070887 cellular response to chemical stimulus 6 0.00443
GO:0006873 cellular ion homeostasis 6 0.00821
GO:0055082 cellular chemical homeostasis 6 0.00844
GO:0015980 energy derivation by oxidation of organic compounds 5 0.00158
GO:0006935 chemotaxis 5 0.00321
GO:0042330 taxis 5 0.00342
GO:0045333 cellular respiration 4 0.00333
GO:0022900 electron transport chain 4 0.00424
GO:0051260 protein homooligomerization 4 0.00424
GO:0001666 response to hypoxia 4 0.00965
GO:0030595 leukocyte chemotaxis 3 0.00428
GO:0060326 cell chemotaxis 3 0.00479
GO:0022904 respiratory electron transport chain 3 0.00826
GO:0050900 leukocyte migration 3 0.00965
GO:0048247 lymphocyte chemotaxis 2 0.00418
GO:0019430 removal of superoxide radicals 2 0.00432
GO:0071451 cellular response to superoxide 2 0.00447
GO:0071450 cellular response to oxygen radical 2 0.00464
GO:0000303 response to superoxide 2 0.00808
GO:0000305 response to oxygen radical 2 0.00933
Molecular function
GO:0008009 chemokine activity 5 0.00014
GO:0001664 G-protein-coupled receptor binding 5 0.00112
GO:0005126 cytokine receptor binding 5 0.00421
GO:0005125 cytokine activity 5 0.00486
GO:0046870 cadmium ion binding 2 0.00956
List of relevant GO annotated from the set of upregulated transcripts with an absolute FC.1.5 and p,0.01 in response to PGC-1a-overexpression. Only GOs with more
than one gene observed are shown. The first column lists the GO term identifier, the second the GO term description, the third the number of genes that are annotated
with this GO term, and the fourth the false discovery rate adjusted p value of that term.
doi:10.1371/journal.pone.0029985.t002
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twitch adult isoforms (MYH7 and MYL3), as shown previously
[33]. Our finding contrasts with the activation in skm-specific
PGC-1a transgenic mice of contractile protein genes characteristic
of type I fibers together with mitochondrial protein genes in
putative type II muscles [5], or the increase in type IIx and IIb
fibers in different skm beds in skm-specific PGC-1a knockout mice
[10]. Our finding is instead consistent with a range of evidence
that other signals influence the fiber phenotype besides PGC-1a.
First, only a discrete number of type I and IIa fibers were
distinguished in the plantaris muscle (type IIb fiber-rich) in skm-
specific PGC-1a transgenic mice [5]. Moreover, the composition
of fibers in the soleus muscle (type I fiber-rich) was not altered in
PGC-1a knockout mice [9]. Additionally, there was no attenua-
tion of the induction of IIb-to-IIa fiber-type transformation by
endurance exercise in skm-specific PGC-1a knockout mice [8].
A number of genes that are highly regulated by PGC-1a in the
cultured skm cells are involved in metabolic control and we
provide an insight into the function of the potentially affected
pathways. One of the upregulated genes was FITM1/FIT1, which
was downregulated by skm tissue culture [25] and thereby rescued
by PGC-1a. The FIT1 gene is abundantly expressed in mouse and
human skm and its forced expression in cultured HEK293 cells
strongly enhances the formation of lipid droplets with only a
modest increase in triglyceride levels [28]. In line with this, we
found that in muscle cells provided with oleate PGC-1a enhances
the formation of lipid droplets, although these exhibit a lower
mean area value, and moderately increases the triglyceride
content. Noteworthy, in the brown fat cell line IMBAT-1, PGC-
1a induced the gene encoding the cell death-inducing DFFA-like
effector A (CIDEA), which in nonadipogenic cell lines promotes
lipid droplet accumulation as well [34]. It has been consistently
observed that transgenic overexpression of PGC-1a in skm
increases lipid droplet and triglyceride accumulation, but that
such an effect is linked to induction of the expression of the fatty
acid translocase FAT/CD36 gene [6,19]. FAT/CD36 enhances
fatty acid uptake and triglyceride synthesis in cultured skm cells
[35]. However, we found no upregulation of FAT/CD36 in
response to PGC-1a in cultured skm cells.
Other PGC-1a-regulated genes related to metabolic control are
the calmodulin CALM1 and its regulator ARPP-21, which are
both downregulated. Calmodulins (CALM1, CALM2 and
CALM3) are signal transducers that decode elevations in
Figure 2. Genes regulated by both PGC-1a-overexpression in
cultured skm cells and skm cultures in comparison to skm
tissue. Heat map including the genes (Gene symbol/Gene ID for Entrez
Gene) in Table 1 (PGC-1a- versus control-skm cells) that were also found
to be differentially expressed after human skm culture according to
Table S2 from [25] (cultured skm cells versus skm tissue). Each cell
displays the absolute fold change in the corresponding comparison and
is filled according to the color gradient shown at the top (green and red
for down and upregulated genes, respectively).
doi:10.1371/journal.pone.0029985.g002
Table 3. Genes validated for differential expression in PGC-1a-overexpressing cultured muscle cells.
RefSeq Gene symbol Gene description FC P value
Upregulated
NM_002854.2 PVALB parvalbumin +12.45 4.08E-8
NM_000584.2 IL8 interleukin 8 +2.81 0.03
NM_002993.2 CXCL6 chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) +2.51 0.006
NM_002985.2 CCL5 chemokine (C-C motif) ligand 5 +4.21 0.0004
NM_005623.2 CCL8 chemokine (C-C motif) ligand 8 +2.64 0.001
NM_001151.2 SLC25A4 solute carrier family 25 (mitochondrial carrier; adenine nucleotide
translocator), member 4
+2.91 0.0009
NM_020529.1 NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells
inhibitor, alpha
+1.39 0.04
NM_003039.1 SLC2A5 solute carrier family 2 (facilitated glucose/fructose transporter), member 5 +1.46 0.04
NM_203402.1 FITM1 fat storage-inducing transmembrane protein 1 +2.86 0.0008
Downregulated
NM_016300.4 ARPP-21 cyclic AMP-regulated phosphoprotein, 21 kD 22.04 0.05
NM_006888.2 CALM1 calmodulin 1 (phosphorylase kinase, delta) 21.71 0.04
List of genes with changed expression levels in response to PGC-1a overexpression in cultured muscle cells as validated by RT and real-time PCR and ordered as in
Table 1. For each gene, the FC in gene expression was calculated from the mean values in PGC-1a-cells versus control cells from six independent experiments
performed in triplicate. FC has a positive symbol for upregulated genes and a negative symbol for downregulated genes. All columns are as in Table 1.
doi:10.1371/journal.pone.0029985.t003
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calmodulins, thereby preventing binding to its targets [38].
Calmodulins are the calcium-modulated d subunit of the
phosphorylase kinase enzyme, which is composed of four different
subunits a, b, c and d. The c subunit has catalytic activity and the
others are regulatory subunits [39]. Phosphorylase kinase
phosphorylates and activates glycogen phosphorylase, the rate-
limiting enzyme of glycogenolysis. We show that glycogen
phosphorylase is markedly inactivated in PGC-1a-cells and this
is coupled to an increase in the storage of glucose as glycogen,
whereas glycogen synthase activity is not affected. A stimulating
effect of PGC-1a on glycogen storage has previously been reported
in mice with skm-specific overexpression of PGC-1a, and this was
associated with a reduced degree of phosphorylation of glycogen
phosphorylase, suggesting inactivation of the enzyme as well [6].
However, in this transgenic mouse model the underlying
mechanism was the reduction in the mRNA levels of phosphor-
ylase kinase a subunit and glycogen phosphorylase. In our cell
system, enhancement of glucose transport by PGC-1a, which
could account for part of the increase in glycogen storage, was not
observed. This is in contrast to the enhancement of glucose uptake
by PGC-1a observed in isolated epitrochlearis muscle from skm-
specific PGC-1a transgenic mice [6] and in other cultured muscle
cells, such as L6 [40] and C2C12 [18] cells, in which forced
expression of PGC-1a stimulated glucose uptake.
The gene that was most highly induced by PGC-1a in the
cultured skm cells, PVALB, is also involved in calcium binding and
signaling. PVALB protein is present mostly in rodent fast-twitch
fibers and is involved in muscle relaxation after contraction [41].
PVALB has previously been identified as a main target gene of
PGC-1a: in PGC-1a knockout mice, a marked reduction of
PVALB mRNA levels was observed in the cerebrum, retina and
heart; conversely a robust increase was detected after PGC-1a
overexpression in neuroblastoma cells [42]. Remarkably, in that
study, only a tendency for a reduction in PVALB gene expression
was found in skm, probably because PGC-1a is mostly expressed
in slow-twitch and PVALB in fast-twitch fibers. To summarize, the
calcium signaling CALM1 and PVALB genes are targets of PGC-
1a in muscle cells. In this regard, there is a well known relationship
between calcium signaling and PGC-1a in skm, which involves the
induction of the PGC-1a gene in response to cellular calcium
influx [3,4] and the action of PGC-1a as a downstream effector of
the calcium/calcineurin pathway [3].
A striking finding in our oligonucleotide microarray analysis was
the induction of a transcriptional cytokine gene program by PGC-
1a. The GO analysis of upregulated genes revealed several
Biological processes in which cytokines are involved and
chemokine/cytokine activity as the most regulated Molecular
function. Cytokine gene members of the CXC chemokine family
[43], such as IL-8/CXCL8 and CXCL6 and CC chemokines,
such as CCL5, CCL8 and CCL2, were among the most
upregulated genes. Furthermore, skm cell IL-8 protein content
was highly increased by PGC-1a, although no secretion of IL-8
into the media could be detected. Cytokines are known to be
produced and secreted by skm (the so-called myokines), mainly in
response to exercise, and exert either autocrine, paracrine or
endocrine effects [44,45]. In particular, IL-8 gene expression is
greatly increased in contracting muscle, accompanied by only a
small and transient net release in plasma, and has been proposed
to participate in the exercise-induced angiogenesis of skm [46].
CCL5/RANTES is upregulated similarly in skm following acute
resistance exercise in young and old men [47]. CCL2 is
upregulated in idiopathic inflammatory myopathies and stimulates
the proliferation of cultured myoblasts, as reviewed in [48].
Nevertheless, it is unclear whether some myokines are derived
from infiltrated immune cells and result from an inflammatory
reaction due to strenuous exercise [44]. Previous studies with
cultured human myoblasts have shown, however, the constitutive
gene expression of IL-1alpha, IL-6, IL-8 and RANTES [49],
whereas IL-1beta, TNF-alpha [49] and CCL2 [48,49] were
detected only after treatment with pro-inflammatory stimuli. Our
data conflict with the proposal that PGC-1a acts as a suppressor of
the inflammatory response in skm [50]. The observations that
support this concept come from skm-specific PGC-1a knockout
mice, in which the expression of the inflammation marker genes
TNF-alpha and IL-6 is increased in both skm and derived muscle
cells in culture [7]; from skm-specific PGC-1a transgenic mice
[24], which show reduced levels of TNF-alpha and IL-6; and
adenoviral-mediated PGC-1a overexpression in C2C12 myotubes,
which led to reduced TNF-alpha and IL-6 gene expression [7].
Remarkably, neither IL-6 nor TNF-alpha was detected as being
regulated in the cultured skm cells in the current study. However,
some of the myokines that were activated by PGC-1a, such as IL-8
and CCL5/RANTES, are known to be constitutively expressed by
skm cells and upregulated by exercise, like PGC-1a [3,4].
Finally, we observed slight upregulation of the gene encoding
NFKBIA, which is an inhibitor of the NF-kB complex, by PGC-
1a. NF-kB activates the expression of several inflammatory
cytokine genes, including IL-8, CCL5/RANTES and CCL2/
MCP1, and antioxidant enzyme genes [51]. NF-kB is activated in
exercise and is considered to play a role in exercise-induced
adaptations in skm, as PGC-1a is [52]. However, NF-kB
Figure 3. Upregulation of IL-8 and FITM1 protein content by
PGC-1a-overexpression in cultured skm cells. Cultured skm cells
were transduced with Ad-GFP or Ad-PGC-1a. In cell extracts, (A) ELISA
assay for IL-8 and (B) immunoblot analysis of FITM1 were performed. (B)
For FITM1, a-actinin was used as loading control; a representative
image is shown and bands were quantified. (A and B) Data are means 6
SEM from three experiments performed in triplicate. Significance of
differences versus cells treated with Ad-GFP: *p,0.05.
doi:10.1371/journal.pone.0029985.g003
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these data, we hypothesize that PGC-1a and NF-kB belong to
alternative signaling pathways, which direct some skm exercise-
associated effects, such as induction of myokine and antioxidant
enzyme genes, while exerting a negative feedback signal on each
other. On the other hand, activation of NF-kB-dependent
transcription is also involved in several types of muscle atrophy
[54]. Thereby, we suggest that by enhancing the NFKBIA
pathway, PGC-1a could contribute to the prevention of muscle
cell atrophy. For instance, none of the other genes that are known
to be regulated by PGC-1a and involved in atrophy, such as
atrogin-1 and MuRF-1 [22], were detected in the current
microarray analysis.
In conclusion, PGC-1a activates the transcriptional program of
mitochondrial protein genes and mitochondrial biogenesis in
cultured human skm cells, as commonly observed in skm, and
rescues the expression of some of the mitochondrial protein genes
that are downregulated by tissue culture. Factors other than PGC-
1a may be necessary to determine the muscle contractile protein
fiber type. PGC-1a enhances lipid and glycogen storage in skm
cells, while increasing the rate of fatty acid oxidation. The
increased formation of lipid droplets may be linked to the
upregulation of FITM1, and the enhanced glycogen accumulation
to the inactivation of the glycogenolytic enzyme glycogen
phosphorylase. Calcium binding proteins CALM1 and PVALB
are PGC-1a targets in skm cells, adding to the evidence regarding
its relationship with calcium signaling. A remarkable finding is that
PGC-1a induces the expression of several myokines, providing
new insights into the possible relationship between PGC-1a,
inflammation and exercise.
Figure 4. Effect of PGC-1a-overexpression on mitochondrial COX activity, mitochondrial to nuclear DNA ratio and oxidation of
metabolic substrates in cultured muscle cells. Cultured muscle cells were transduced with Ad-GFP or Ad-PGC-1a adenoviruses. (A)
Cytochemical staining of COX activity was performed in cultured skm cells that had been transduced with Ad-GFP (a, b and c) or Ad-PGC-1a (d, e and
f). Images were obtained with a camera (a,b,d,e) or with an inverted microscope at 8006 magnification (c,f). Images from two independent
experiments performed in duplicate were quantitatively analyzed and the data expressed as percentages of the values in the controls: means 6 SEM
are shown on the graph. The significance of the difference is *p,0.005. (B) Cells were harvested and total DNA isolated to measure the ratio of
mitochondrial DNA (mtDNA) content to nuclear DNA (nDNA) content. Data are expressed as a percentage of control. Data are means 6 SEM from
two experiments performed in triplicate. (C–E) Cells were then incubated for 4 h with: (C) 0.5 mM [1-
14C]-palmitate (2.8 mCi/mmol), (D) 10 mM [U-
14C]-
glucose (0.21 mCi/mmol) and (E) 2 mM [U-
14C]-lactate (0.6 mCi/mmol). Production of
14CO2 was subsequently quantified. Data are expressed as means
6 SEM from two experiments performed in sextuplicate. The significance of the difference is *p,0.005 and **p,0.001.
doi:10.1371/journal.pone.0029985.g004
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Skeletal muscle cultures and adenoviral transduction
Myogenic cells and skm biopsies were obtained from a
cryopreserved collection described in [25] that was obtained with
written approval from the Ethics Committee of the Hospital Sant
Joan de De ´u according to Spanish legislation at that time. Written
informed consent by patients devoid of neuromuscular disease was
not sought since all samples were treated anonymously throughout
the study. The ethics committee approved the waiver for consent
for research. Cell differentiation was induced in confluent
myoblast cultures; immediately after initiation of myoblast fusion,
DMEM/M-199 medium (3:1) with 10% FBS (fetal bovine serum),
10 mg/ml insulin, 4 mM glutamine, 25 ng/ml fibroblast growth
factor and 10 ng/ml epidermal growth factor was replaced by
DMEM/M-199 medium (3:1) with 10% FBS and 10 mg/ml
insulin, to further stimulate differentiation. Seven-days after
induction of differentiation, cells were transduced with adenovi-
ruses at a multiplicity of infection of 50 for 4 h. Cells were used 2
days after transduction, being depleted of insulin and FBS 24 h
before the metabolic experiments. An adenovirus expressing
EGFP (enhanced green fluorescent protein) under the control of
the CMV (cytomegalovirus) promoter, Ad-GFP, was used as a
control. The adenovirus expressing mouse PGC-1a cDNA (Ad-
PGC-1a) constructed with the pAdTrack-CMV plasmid has been
described elsewhere [55].
Gene expression analysis
Total RNA was extracted from tissue and cell samples using the
RNeasy minikit (Qiagen, Valencia, CA, USA) and homogenized
using a Polytron (Kynematica Polytron, Westbury, NY, USA).
RNA samples were quantified using the RiboGreen RNA
Quantification Kit (Invitrogen, Paisley, UK), and monitored with
the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA, USA), to ensure high-quality RNA (RNA integrity $8).
Microarray analysis was performed in the Microarray Core
Facility of the Centre de Regulacio ´ Geno `mica (Barcelona, Spain)
using the Human-6 v3.0 Expression BeadChip Kit-Array from
Illumina. Briefly, biotinylated cRNA was prepared using the
Illumina RNA Amplification Kit (Ambion, Austin, TX, USA)
according to the manufacturer’s instructions starting with
Figure 5. Effect of PGC-1a-overexpression on lipid droplets and triglyceride accumulation in cultured muscle cells. Cultured skm cells
were transduced with Ad-GFP or Ad-PGC-1a and incubated with 0.5 mM oleate for 16 h. (A,B,C) Cells were fixed and then stained with Nile Red. (A)
Representative lipid droplet micrographs obtained via confocal microscopy are shown. White bars represent 5 mm. (B) The number of lipid droplets
per cell area and (C) the lipid droplet mean area values were quantified. Data are means 6 SEM of (B) four cells or (C) at least 414 droplets. (D)
Triglyceride content was measured. Data are means 6 SEM of three experiments performed in quadruplicate. (B,C,D) The significance of the
differences versus cells treated with Ad-GFP is *p,0.05 and **p,0.01.
doi:10.1371/journal.pone.0029985.g005
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hybridized on Illumina Human-6 v3.0 Expression BeadChips
following the manufacturer’s instructions. After 16 h of hybrid-
ization arrays were washed, dried and scanned using Illumina
BeadScan software on the Illumina BeadArray scanning system.
Raw intensities were extracted using the GenomeStudio software
(Illumina, San Diego, CA, USA). The data were normalized using
the lumi package [56]. The microarray data are MIAME
compliant and data files have been deposited in GEO Omnibus
(access number GSE28206).
For RT and real-time PCR, an aliquot of 0.5 mg of total RNA
was retro-transcribed with TaqMan RT reagents from Applied
Biosystems (Foster City, CA, USA) using random hexamers and in
a2 0ml total volume reaction. Real-time PCR was performed on
1 ml of the RT reaction mixture with the LightCycler 480 probes
master and TaqMan Gene Expression Assays using the Light-
Cycler 480 Real Time PCR System (Roche Diagnostics,
Mannheim, Germany). Probes for SLC25A4 (Hs00154037_m1),
SLC2A5 (Hs00161720_m1), FITM1 (Hs00416856_g1), PALB
(Hs00161045_m1), ARPP-21 (Hs00372261_m1), CALM1
(Hs00237233_m1) and B2M (Hs99999907_m1) were obtained
from Applied Biosystems. The Crossing Point (CP) values of the
reference probe beta-2 microglobulin (B2M) were subtracted from
the CP values of each target probe (DCP), and the DCP values of
the control cells (transduced with AdGFP) were subtracted from
the DCP values of PGC-1a- overexpressing cells. The data were
expressed as mean values of (1/)2
2DCP or (1/)2
2DDCP. The
significance of differences was estimated using a paired t-test.
In an alternative approach to RT and real-time PCR, Primer
Express Software (Applied Biosystems, Foster City, USA) was used
to design the forward (fp) and reverse (rp) primers: 18S fp 59-
GCCGCTAGAGGTGAAATTCTTG-39 and rp 59-CATTC-
TTGGCAAATGCTTTCG-39; CCL5 fp 59-CTGCATCTG-
CCTCCCCATA-39 and rp 59-GCGGGCAATGTAGGCAAA-
39; CCL8 59-TGCTCATGGCAGCCACTTT-39 and rp 59-
GCAGGTGATTGGAATGGAAACT-39; CXCL2 fp 59-TG-
GGCAGAAAGCTTGTCTCA-39 and rp 59-TCAGCATCT-
TTTCGATGATTTTCTT-3; CXCL6 fp 59-CAGAGCTGCG-
TTGCACTTGT-39 and rp 59-ACACCTGCAGTTTACCAA-
TCGTT-39; IkBa fp 59-CCCAAGCACCCGGATACAG-39 and
rp 59-TCACTCTCTGGCAGCATCTGA-39; IL-6 fp 59-CC-
CCCAGGAGAAGATTCCAA-39 and rp 59-TCAATTCG-
TTCTGAAGAGGTGAGT-39; IL-8 fp 59-CTGGCCGTGG-
CTCTCTTG-39 and rp 59-TTAGCACTCCTTGGCAAA-
ACTG-39. The PCR reaction contained 10 ng of reverse-
transcribed RNA and 10 mlo f2 6 iQ SYBR Green Supermix
(Bio-Rad Laboratories, Barcelona, Spain) plus 900 nM of each
primer. The optimal primer amplification efficiency for each
primer set was assessed and a dissociation protocol was carried out
to ensure a single PCR product. PCR assays were performed on a
MiniOpticon Real-Time PCR Detection System (Bio-Rad).
Thermal cycling conditions were as follows: activation of Taq
DNA polymerase at 95uC for 10 min, followed by 40 cycles of
amplification at 95uC for 15 s and 60uC for 1 min. All analyses
were performed in duplicate and relative RNA levels were
determined using 18S as the internal control.
Statistical analysis and filtering and bioinformatic analysis
This analysis was performed in the Serveis de Suport a la
Recerca of the Universitat de Barcelona. Statistical analysis was
carried out using Bioconductor [57]. The lumi package [56,58]
was used to apply a log2 transformation followed by quantile
normalization to the BeadStudio summarized data. Then, a paired
Figure 6. Effect of PGC-1a-overexpression on glycogen metabolism and glucose uptake in cultured muscle cells. Cultured skm cells
were transduced with Ad-GFP or Ad-PGC-1a. (A) Cells were incubated with 10 mM [U-
14C]-glucose (0.10 mCi/mmol) for 18 h and then harvested to
asses glucose incorporation into glycogen. Data are means 6 SEM from two experiments performed in triplicate. (B) Glucose uptake was measured
using 0.5 mM 2-deoxy-D-[
3H]glucose (0.5 mCi/well). Data are means 6 SEM from two experiments performed in triplicate. (C,D) Cells were harvested
to measure (C) glycogen synthase and (D) glycogen phosphorylase activity. Data are means 6 SEM from three experiments performed in
quadruplicate. The significance of differences versus cells treated with control adenoviruses is indicated as follows: *p,0.05 and **p,0.01.
doi:10.1371/journal.pone.0029985.g006
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differentially expressed in PGC-1a-overexpressers and controls.
Only those genes with a p value smaller than 0.025 and a fold
change greater than 1.5 were selected (Table 1). GO analysis of
differentially upregulated and downregulated genes was carried
out as described in [60].
Immunological methods
Cells were homogenized in buffer A consisting of 50 mM Tris-
HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM phenyl-
methylsulfonyl fluoride, 1 mM NaF, 1 mM Na3VO4, 2 mg/ml
benzamidine, 2 mg/ml leupeptin, 1% (v/v) Nonidet P40, and
1 mM dithiothreitol. Lysates were then gently rocked for 60 min
at 4uC, and stored at 280uC until analysis. Alternatively, to
prepare cell nuclear extracts, cells were homogenized in buffer B
consisting of 10 mM Tris/HCl (pH 7.0) 150 mM KF, 15 mM
EDTA, 600 mM sucrose, 15 mM 2-mercaptoethanol, 17 mg/l
leupeptin, 1 mM benzamidine and 1 mM PMSF. Homogeniza-
tion of extracts was performed with the aid of a syringe 22 G.
Homogenates were centrifuged at 11006g for 10 min at 4uC and
the pellet was collected. This nuclear enriched pellet was
resuspended in the buffer A described above. Protein was resolved
in 10% SDS-PAGE. Antibodies against GFP (8371-2, BD
biosciences, Palo Alto, USA), PGC-1a (ST1202, Merck, Madrid,
Spain), FITM1 (HPA019842, Sigma-Aldrich Madrid, Spain), a-
actin (A2066, Sigma-Aldrich) and a-actinin (CBL231, Chemicon
International, Temecula, CA, USA), were used. Horseradish
peroxidase-conjugated secondary antibodies were used and
membranes were developed with ECL-Plus (GE Healthcare,
Buckinghamshire, UK). Protein bands were revealed and
quantified using a LAS-3000 luminescent image analyzer
(FujiFilm, Tokyo, Japan) or ImageQuant LAS 4000 (GE
Healthcare Life Sciences, Uppsala, Sweden).
The cell extract for ELISA analysis was prepared by scraping
cell monolayers with buffer B. Cell extracts were then sonicated
and added with 1% Triton. The human IL-8 ELISA kit (Thermo
Scientific, Waltham, MA, USA) and 50 ml of cell extracts were
used.
Cytochemistry
For cytochemical staining of COX activity, living cells seeded
on glass coverslips were rinsed with PBS, air-dried for 1 h at room
temperature and preincubated with 1 mM CoCl2, 10% sucrose in
Tris-HCl (pH 7.6) for 15 min at room temperature. After rinsing
with phosphate buffer (0.1 M sodium phosphate (pH 7.6) with
10% sucrose), the cells were incubated in the same buffer including
1 mg/ml cytochrome c, 1 mg/ml DAB (3-39 diaminobenzidine-
tetrahydrochloride dihydrate) and 0.1 mg/ml catalase for 6 h at
37uC. DAB, a compound that replaces complex III in the
respiratory chain as an electron source and becomes a brown
precipitate when it is oxidized by cytochrome c. The coverslips
were rinsed once with the phosphate buffer and then PBS and
distilled water. Cells were then fixed with PBS containing 4% (w/
v) paraformaldehyde for 20 min, rinsed with PBS and mounted
using Immuno Floure Mounting Medium. Coverslips were
examined under an Olympus LH50A microscope and images
were taken and then analyzed using the Multi Gauge software 3.0.
To stain for intracellular lipid droplets we used a fluorescent
hydrophobic probe. Muscle cells seeded on glass coverslips were
fixed as described above. Paraformaldehyde was aspirated off and
the cells were rinsed with PBS. Nile red dissolved in DMSO to
form a 1 mM stock solution was added in PBS (at 1:1000 dilution)
and incubated for 5 min. This was then aspirated and the cells
rinsed with PBS. Coverslips were mounted with Immuno Floure
Mounting Medium. Fluorescence images were obtained using a
Leica TCS SP2 microscope. The size and number of lipid droplets
were measured using AnalySIS (Soft Imaging System, Olympus,
Germany).
Metabolic analysis
We used [U-
14C]-glucose to detect the incorporation of
radioactivity into glycogen. We used [U-
14C]-glucose, [1-
14C]-
palmitate or [U-
14C]-lactate to detect oxidation to CO2 as
previously described [61], except that for CO2 measurement cells
were grown in 24-well plates. [U-
14C]-glucose incorporation into
glycogen, glycogen synthase and glycogen phosphorylase activities
was measured as described in [61]. 2-Deoxy-D-glucose uptake was
measured as described in [62]. Sodium salts of palmitic and oleic
acids were prepared in deionized water containing 1.2 equivalents
of NaOH at 70uC, until an optically clear dispersion was obtained.
The fatty acid salt solution was added to DMEM containing fatty
acid-free bovine serum albumin (BSA) with continuous agitation at
a fatty acid: BSA molar ratio of 5:1. To determine the triglyceride
content extracts were prepared by scraping cell monolayers into a
buffer consisting of 50 mM Tris (pH 7.9), 100 mM KCl, 20 mM
KF, 0.5 mM EDTA and 0.05% Lubrol PX and applying three 5 s
pulses of sonication. Homogenates were centrifuged at 11.000 g
for 15 min and the resulting supernatants were collected. Protein
concentration was measured using the Bio-Rad protein assay
reagent. TAGs were measured enzymatically using a kit from
Biosystems (Barcelona, Spain).
To determine the mitochondrial DNA content relative to the
nuclear DNA content, total DNA was isolated from cells using the
TRI Reagent (Sigma-Aldrich) and following manufacturer’s
protocol. Real-time PCR was carried out with the LightCycler
system using SYBRH Green JumpStart
TM Taq Ready Mix
(Sigma-Aldrich). Primers for mitochondrial cytochrome c oxidase
I, COX1, were: fp 59-CCCCTGCCATAACCCAATACC A-39;
rp 59-CCAGCAGCTAGGACTGGGAGAGA-39. Primers for
nuclear myogenin (myogenic factor 4), MYOG, were: 59-
AGGTGCTGTCAGGAAGCAAGGA-39; antisense 59-TAGGG-
GGAGGAGGGAACAAGGA-39. The Ct values for the COX1
and MYOG probes were obtained and the ratio calculated.
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